Many studies have demonstrated that the inhibition of TNF-a and IL1B is helpful in decreasing IL6 production during MI, and reduces infarct size, relieves cardiac remodeling, as well as improves cardiac function after MI (33–35). This evidence concerns the gene IL1B and myocardial infarction.